The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Thanks for replying Stevie, my concern is if they do similar to what RR did which I believe was a rights issue to buy 3 shares every 1 share owned, I wouldn’t have the funds available compared to the amount of shares I own. Choices choices.
The point I’m getting at is if a business currently isn’t off the starting block , how long can they keep those types of losses up?! It really isn’t rocket science from a business perspective that when your losing millions the business won’t stay a float for long periods of time in these circumstances.
I’ve been invested here since last summer and have no intention of selling as I can see the possible potential of the company in the future ( if and when they do get off that starting block) and am willing to lose my initial investment as a gamble. But that rns really isn’t “ GREAT” as some on here are making out. Looking at the SP that shows this also.
Please elaborate how the amount of loss indicated in this rns is a great rns please?
I’m a long term holder but can’t see how this can be seen as a great RNS. The business can’t continue losses like that for long before the plug is pulled.
I don’t see how it would matter then as we would have the letter of no objection. Totally different scenario.
FCA is currently our biggest hurdle . If we take away one of their biggest arguments , which was shareholders profiting, while claimants lose out, that’s a step in the rite direction, and a point they can once again use in court taken away from them.
I would say keeping the share prices lower is the intention ,so as the same occurrence doesn’t happen if SOA2 is to go ahead again which removes one of the fcas arguments regarding shareholders gaining.
Also showing a rights issue wouldn’t be ideal at the current SP level.